No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
No analyst estimates.
No tracked top-trader positions in SLBT as of Oct 24, 09:34 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jun 18, 2026
Period ending
Dec 31, 2025
Earnings per share
EPS comparison unavailable
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Dec 31, 2025 | Jun 18, 2026 | Unavailable | - | $2.2M No estimateYear ended Dec 31, 2025 · SEC filing · Operating company: SL Bio Ltd | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
This company is not yet profitable.
Valuation
Quality
Growth
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace